Next-Generation Biologics Market Report

Europe Next-Generation Biologics Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 12, 2019
  • PAGES：139
  • REPORT CODE：GMM316268
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Next-Generation Biologics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 12.0% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Next-Generation Biologics Market Segmentations:

    By Player:

    • Allergan

    • Kyowa Hakko Kirin

    • Eli Lilly

    • Roche

    • Novo Nordisk

    • Pfizer

    • Bayer

    • Molecular Partners

    • Biogen Idec

    • Sanofi

    By Type:

    • Antibodies

    • Regenerative medicine

    • Insulins

    • Growth hormones

    • Other

    By End-User:

    • Medical

    • Scientific Research

    • Other

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Next-Generation Biologics Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Next-Generation Biologics Market Size and Growth Rate of Antibodies from 2014 to 2026

    • 1.3.2 Europe Next-Generation Biologics Market Size and Growth Rate of Regenerative medicine from 2014 to 2026

    • 1.3.3 Europe Next-Generation Biologics Market Size and Growth Rate of Insulins from 2014 to 2026

    • 1.3.4 Europe Next-Generation Biologics Market Size and Growth Rate of Growth hormones from 2014 to 2026

    • 1.3.5 Europe Next-Generation Biologics Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Next-Generation Biologics Market Size and Growth Rate of Medical from 2014 to 2026

    • 1.4.2 Europe Next-Generation Biologics Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • 1.4.3 Europe Next-Generation Biologics Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Next-Generation Biologics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Next-Generation Biologics by Major Types

      • 3.4.1 Market Size and Growth Rate of Antibodies

      • 3.4.2 Market Size and Growth Rate of Regenerative medicine

      • 3.4.3 Market Size and Growth Rate of Insulins

      • 3.4.4 Market Size and Growth Rate of Growth hormones

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Next-Generation Biologics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Next-Generation Biologics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Next-Generation Biologics for Medical

      • 4.4.2 Market Size and Growth Rate of Next-Generation Biologics for Scientific Research

      • 4.4.3 Market Size and Growth Rate of Next-Generation Biologics for Other

    5 Market Analysis by Major Regions

    • 5.1 Europe Next-Generation Biologics Production Analysis by Top Regions

    • 5.2 Europe Next-Generation Biologics Consumption Analysis by Top Regions

    • 5.3 Europe Next-Generation Biologics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.3 France Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Production, Import, Consumption and Export Analysis

    6 Product Circulation of Next-Generation Biologics Market among Top Countries

    • 6.1 Top 5 Export Countries in Next-Generation Biologics Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Next-Generation Biologics Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Next-Generation Biologics Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Next-Generation Biologics Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Next-Generation Biologics Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Next-Generation Biologics Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Next-Generation Biologics Landscape Analysis

    • 7.1 Germany Next-Generation Biologics Landscape Analysis by Major Types

    • 7.2 Germany Next-Generation Biologics Landscape Analysis by Major End-Users

    8. UK Next-Generation Biologics Landscape Analysis

    • 8.1 UK Next-Generation Biologics Landscape Analysis by Major Types

    • 8.2 UK Next-Generation Biologics Landscape Analysis by Major End-Users

    9. France Next-Generation Biologics Landscape Analysis

    • 9.1 France Next-Generation Biologics Landscape Analysis by Major Types

    • 9.2 France Next-Generation Biologics Landscape Analysis by Major End-Users

    10. Italy Next-Generation Biologics Landscape Analysis

    • 10.1 Italy Next-Generation Biologics Landscape Analysis by Major Types

    • 10.2 Italy Next-Generation Biologics Landscape Analysis by Major End-Users

    11. Spain Next-Generation Biologics Landscape Analysis

    • 11.1 Spain Next-Generation Biologics Landscape Analysis by Major Types

    • 11.2 Spain Next-Generation Biologics Landscape Analysis by Major End-Users

    12. Poland Next-Generation Biologics Landscape Analysis

    • 12.1 Poland Next-Generation Biologics Landscape Analysis by Major Types

    • 12.2 Poland Next-Generation Biologics Landscape Analysis by Major End-Users

    13. Russia Next-Generation Biologics Landscape Analysis

    • 13.1 Russia Next-Generation Biologics Landscape Analysis by Major Types

    • 13.2 Russia Next-Generation Biologics Landscape Analysis by Major End-Users

    14. Switzerland Next-Generation Biologics Landscape Analysis

    • 14.1 Switzerland Next-Generation Biologics Landscape Analysis by Major Types

    • 14.2 Switzerland Next-Generation Biologics Landscape Analysis by Major End-Users

    15. Turkey Next-Generation Biologics Landscape Analysis

    • 15.1 Turkey Next-Generation Biologics Landscape Analysis by Major Types

    • 15.2 Turkey Next-Generation Biologics Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Landscape Analysis by Top Countries

      • 16.3.1 Denmark Next-Generation Biologics Market Volume and Growth Rate

      • 16.3.2 Finland Next-Generation Biologics Market Volume and Growth Rate

      • 16.3.3 Norway Next-Generation Biologics Market Volume and Growth Rate

      • 16.3.4 Sweden Next-Generation Biologics Market Volume and Growth Rate

      • 16.3.6 Iceland Next-Generation Biologics Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Landscape Analysis by Top Countries

      • 17.3.1 Belgium Next-Generation Biologics Market Volume and Growth Rate

      • 17.3.2 Netherlands Next-Generation Biologics Market Volume and Growth Rate

      • 17.3.3 Luxembourg Next-Generation Biologics Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Landscape Analysis by Top Countries

      • 18.3.1 Estonia Next-Generation Biologics Market Volume and Growth Rate

      • 18.3.2 Latvia Next-Generation Biologics Market Volume and Growth Rate

      • 18.3.3 Lithuania Next-Generation Biologics Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Allergan

      • 19.1.1 Allergan Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Kyowa Hakko Kirin

      • 19.2.1 Kyowa Hakko Kirin Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Eli Lilly

      • 19.3.1 Eli Lilly Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Roche

      • 19.4.1 Roche Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Novo Nordisk

      • 19.5.1 Novo Nordisk Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Pfizer

      • 19.6.1 Pfizer Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Bayer

      • 19.7.1 Bayer Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Molecular Partners

      • 19.8.1 Molecular Partners Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Biogen Idec

      • 19.9.1 Biogen Idec Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Sanofi

      • 19.10.1 Sanofi Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 67 Figures and 118 Tables)

    • Figure Product Picture

    • Figure Europe Next-Generation Biologics Market Size and Growth Rate of Antibodies from 2014 to 2026

    • Figure Europe Next-Generation Biologics Market Size and Growth Rate of Regenerative medicine from 2014 to 2026

    • Figure Europe Next-Generation Biologics Market Size and Growth Rate of Insulins from 2014 to 2026

    • Figure Europe Next-Generation Biologics Market Size and Growth Rate of Growth hormones from 2014 to 2026

    • Figure Europe Next-Generation Biologics Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Europe Next-Generation Biologics Market Size and Growth Rate of Medical from 2014 to 2026

    • Figure Europe Next-Generation Biologics Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • Figure Europe Next-Generation Biologics Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Germany Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure UK Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure France Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Next-Generation Biologics Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Next-Generation Biologics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Next-Generation Biologics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Next-Generation Biologics by Different Types from 2014 to 2026

    • Table Consumption Share of Next-Generation Biologics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Antibodies

    • Figure Market Size and Growth Rate of Regenerative medicine

    • Figure Market Size and Growth Rate of Insulins

    • Figure Market Size and Growth Rate of Growth hormones

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Next-Generation Biologics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Next-Generation Biologics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Medical

    • Figure Market Size and Growth Rate of Scientific Research

    • Figure Market Size and Growth Rate of Other

    • Table Europe Next-Generation Biologics Production by Major Regions

    • Table Europe Next-Generation Biologics Production Share by Major Regions

    • Figure Europe Next-Generation Biologics Production Share by Major Countries and Regions in 2014

    • Table Europe Next-Generation Biologics Consumption by Major Regions

    • Table Europe Next-Generation Biologics Consumption Share by Major Regions

    • Table Germany Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table UK Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table France Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Italy Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Spain Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Poland Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Russia Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Switzerland Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Turkey Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Next-Generation Biologics Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Next-Generation Biologics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Next-Generation Biologics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Next-Generation Biologics Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Germany Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Germany Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Germany Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table UK Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table UK Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table UK Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table UK Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table France Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table France Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table France Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table France Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Italy Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Italy Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Italy Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Italy Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Spain Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Spain Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Spain Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Spain Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Poland Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Poland Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Poland Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Poland Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Russia Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Russia Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Russia Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Russia Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Switzerland Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Switzerland Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Switzerland Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Turkey Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Turkey Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Turkey Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Next-Generation Biologics Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Next-Generation Biologics Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Next-Generation Biologics Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Next-Generation Biologics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Kyowa Hakko Kirin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kyowa Hakko Kirin

    • Figure Sales and Growth Rate Analysis of Kyowa Hakko Kirin

    • Figure Revenue and Market Share Analysis of Kyowa Hakko Kirin

    • Table Product and Service Introduction of Kyowa Hakko Kirin

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Molecular Partners

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Molecular Partners

    • Figure Sales and Growth Rate Analysis of Molecular Partners

    • Figure Revenue and Market Share Analysis of Molecular Partners

    • Table Product and Service Introduction of Molecular Partners

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US